Elizabeth J Wilk[Author] - Search Results

Year	Number of Results
2023	7
2024	2

1

Computational Advancements in Cancer Combination Therapy Prediction.

Flanary VL, Fisher JL, Wilk EJ, Howton TC, Lasseigne BN. Flanary VL, et al. Among authors: wilk ej. JCO Precis Oncol. 2023 Sep;7:e2300261. doi: 10.1200/PO.23.00261. JCO Precis Oncol. 2023. PMID: 37824797

2

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.

Wilk EJ, Howton TC, Fisher JL, Oza VH, Brownlee RT, McPherson KC, Cleary HL, Yoder BK, George JF, Mrug M, Lasseigne BN. Wilk EJ, et al. Mol Med. 2023 May 22;29(1):67. doi: 10.1186/s10020-023-00664-z. Mol Med. 2023. PMID: 37217845 Free PMC article.

3

Ten simple rules for using public biological data for your research.

Oza VH, Whitlock JH, Wilk EJ, Uno-Antonison A, Wilk B, Gajapathy M, Howton TC, Trull A, Ianov L, Worthey EA, Lasseigne BN. Oza VH, et al. Among authors: wilk ej. PLoS Comput Biol. 2023 Jan 5;19(1):e1010749. doi: 10.1371/journal.pcbi.1010749. eCollection 2023 Jan. PLoS Comput Biol. 2023. PMID: 36602970 Free PMC article.

4

Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.

Fisher JL, Wilk EJ, Oza VH, Gary SE, Howton TC, Flanary VL, Clark AD, Hjelmeland AB, Lasseigne BN. Fisher JL, et al. Among authors: wilk ej. FEBS Open Bio. 2024 May;14(5):803-830. doi: 10.1002/2211-5463.13796. Epub 2024 Mar 26. FEBS Open Bio. 2024. PMID: 38531616 Free PMC article.

5

The landscape of SETBP1 gene expression and transcription factor activity across human tissues.

Whitlock JH, Wilk EJ, Howton TC, Clark AD, Lasseigne BN. Whitlock JH, et al. Among authors: wilk ej. bioRxiv [Preprint]. 2023 Oct 14:2023.08.08.551337. doi: 10.1101/2023.08.08.551337. bioRxiv. 2023. PMID: 37873221 Free PMC article. Updated. Preprint.

6

Cell-type-specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1^S858R Schinzel Giedion Syndrome mice.

Whitlock JH, Soelter TM, Howton TC, Wilk EJ, Oza VH, Lasseigne BN. Whitlock JH, et al. Among authors: wilk ej. J Cell Mol Med. 2023 Nov;27(22):3565-3577. doi: 10.1111/jcmm.18001. Epub 2023 Oct 23. J Cell Mol Med. 2023. PMID: 37872881 Free PMC article.

7

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.

Williams AS, Wilk EJ, Fisher JL, Lasseigne BN. Williams AS, et al. Among authors: wilk ej. Cancer Rep (Hoboken). 2023 Sep;6(9):e1874. doi: 10.1002/cnr2.1874. Epub 2023 Aug 2. Cancer Rep (Hoboken). 2023. PMID: 37533331 Free PMC article.

8

The landscape of SETBP1 gene expression and transcription factor activity across human tissues.

Whitlock JH, Wilk EJ, Howton TC, Clark AD, Lasseigne BN. Whitlock JH, et al. Among authors: wilk ej. PLoS One. 2024 Jan 2;19(1):e0296328. doi: 10.1371/journal.pone.0296328. eCollection 2024. PLoS One. 2024. PMID: 38165902 Free PMC article.

9

Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.

Williams AS, Wilk EJ, Fisher JL, Lasseigne BN. Williams AS, et al. Among authors: wilk ej. bioRxiv [Preprint]. 2023 Jun 15:2023.04.11.536431. doi: 10.1101/2023.04.11.536431. bioRxiv. 2023. PMID: 37090499 Free PMC article. Updated. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year